M/25/065 – Celltrion/ImClone Systems
Transaction details
The proposed acquisition by Celltrion, Inc., through Celltrion USA, Inc., of sole control of ImClone Systems LLC has been notified to the Competition and Consumer Protection Commission.
| Notification date | Decision date |
|---|---|
| Thursday October 16, 2025 | |
| Parties Involved | Business activities |
|---|---|
| Celltrion, Inc. | Celltrion, Inc. is a is a publicly traded South Korean biopharmaceutical company engaged in the development and global supply of biosimilars, biologics and small molecule drugs. |
| Celltrion USA, Inc. | Celltrion USA, Inc. is a Delaware-incorporated subsidiary of Celltrion, Inc. Celltrion USA, Inc. is active in the distribution and regulatory management of Celltrion, Inc.'s pharmaceutical products in the United States. Celltrion USA, Inc. has a presence in the State through its subsidiary, Celltrion Healthcare Ireland Limited. |
| ImClone Systems LLC | ImClone Systems LLC is incorporated as a limited liability company in Delaware, United States. ImClone Systems LLC is active in the pharmaceutical sector through its biopharmaceutical manufacturing facility in Branchburg, New Jersey which produces active pharmaceutical ingredients (APIs). |
| Economic sector | Media merger |
|---|---|
| Healthcare | No |
| Submissions from third parties due by: | |
|---|---|
| Phase 1 | Phase 2 |
| Thursday, October 30, 2025 | |
| Current status: Active |
|---|
| Simplified Merger Notification |
| Authorised Officer Assigned | Contact Details |
|---|---|
| Jack Kelly | jackkelly@ccpc.ie |
| Aodhán Frain | aodhanfrain@ccpc.ie |
Media enquiries: communications@ccpc.ie
Haven’t found what you’re looking for?
Competition and Consumer Protection Commission
PO Box 12585, Dublin 1, D01 C576
Tel +353 (0)1 402 5500
Consumer helpline 01 402 5555